Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical Co

05/08/2025 07:33

Aug 5 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.17                1.88             10.00    
                 (+15.1 pct)         (+1.3 pct)       (+28.4 pct) 
  Operating     loss 143 mln         loss 89 mln        200 mln   
  Recurring     loss 117 mln         loss 64 mln        250 mln   
  Net           loss 108 mln         loss 11 mln        200 mln   
                                                     (+210.4 pct) 
  EPS           loss 3.12 yen       loss 0.32 yen      5.76 yen   
  Ann Div                             3.00 yen         3.00 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             3.00 yen         3.00 yen   
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T